Cedar Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-160
Closed -$14.8K 198
2024
Q4
$14.8K Sell
160
-310
-66% -$27.9K 0.01% 134
2024
Q3
$39.4K Hold
470
0.01% 165
2024
Q2
$32.2K Buy
470
+160
+52% +$10.7K 0.01% 180
2024
Q1
$22.7K Buy
+310
New +$23.8K 0.01% 205
2023
Q4
Sell
-500
Closed -$37.5K 286
2023
Q3
$37.5K Hold
500
0.01% 170
2023
Q2
$38.5K Hold
500
0.01% 171
2023
Q1
$41.5K Sell
500
-800
-62% -$66.3K 0.02% 165
2022
Q4
$112K Sell
1,300
-72
-5% -$5.7K 0.06% 108
2022
Q3
$85K Sell
1,372
-36
-3% -$2.27K 0.04% 133
2022
Q2
$87K Sell
1,408
-117
-8% -$7.24K 0.04% 139
2022
Q1
$91K Buy
1,525
+117
+8% +$7.48K 0.04% 142
2021
Q4
$102K Buy
1,408
+60
+4% +$4.13K 0.04% 145
2021
Q3
$94K Hold
1,348
0.04% 134
2021
Q2
$93K Hold
1,348
0.04% 140
2021
Q1
$87K Hold
1,348
0.04% 132
2020
Q4
$79K Buy
1,348
+48
+4% +$2.9K 0.04% 120
2020
Q3
$82K Hold
1,300
0.05% 112
2020
Q2
$100K Hold
1,300
0.07% 102
2020
Q1
$97K Buy
1,300
+200
+18% +$13.8K 0.07% 103
2019
Q4
$71K Buy
+1,100
New +$71.6K 0.04% 81
2018
Q4
Sell
-83
Closed -$6K 170
2018
Q3
$6K Hold
83
﹤0.01% 139
2018
Q2
$6K Buy
83
+43
+108% +$3.04K ﹤0.01% 154
2018
Q1
$3K Buy
+40
New +$3.18K ﹤0.01% 120

Other funds holding GILD

Cedar Wealth Management's GILD Position: Q1 2025 in Review

Cedar Wealth Management sold out of Gilead Sciences (GILD) in Q1 2025, closing a stake of 160 shares — an estimated $14.8K sold.

Cedar Wealth Management first reported a position in GILD in Q1 2018 and held it in 23 quarters. The position peaked at $112K in Q4 2022. 2,013 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Cedar Wealth Management reported no remaining Gilead Sciences position as of Q1 2025 after selling out during the quarter.
  • Cedar Wealth Management sold 160 Gilead Sciences shares in Q1 2025, an estimated $14.8K.
  • Cedar Wealth Management first reported a position in Gilead Sciences in Q1 2018 and held it in 23 quarters.
  • Cedar Wealth Management's Gilead Sciences position peaked at $112K in Q4 2022.
  • 2,013 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Cedar Wealth Management's 13F filing for Q1 2025, filed 9 May 2025.